Notification of Results

Cookie Notification

We use cookies to collect information about how our website is used and to improve the visitor experience. You can change your browser's cookie settings at any time. Please review our privacy policy for more information. OK

Oct 21, 2010

Porton Down, UK, 21 October 2010: GW Pharmaceuticals plc (AIM: GWP) will be announcing its preliminary financial results for the year end 30 September 2010 on Tuesday 23 November 2010.

Enquiries:

Financial Dynamics: +44 20 78313113

Ben Atwell/ John Dineen

Notes to Editors

About GW

GW was founded in 1998 and listed on the AIM, a market of the London Stock Exchange, in June 2001. Operating under license from the UK Home Office, the company researches and develops cannabinoid pharmaceutical products for patients who suffer from a range of serious ailments, in particular multiple sclerosis and cancer pain. GW has assembled a large in-house scientific team with expertise in cannabinoid science as well as experience in the development of both plant-based prescription pharmaceutical products and medicines containing controlled substances. GW occupies a world leading position in cannabinoids and has developed an extensive international network of the most prominent scientists in the field. For more information, visit www.gwpharm.com

Recent News